3D Systems Announces Acquisition of Volumetric Biotechnologies

NEXT STORY
Checkmate Pharmaceuticals Announces CEO Transition
PREV STORY
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Celon Pharma Files for Approval of Phase II Trial of CPL’280, a Second Generation GPR40 Agonist, in Type 2 Diabetes

author_avatar
NASDAQ Market News

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020

author_avatar
NASDAQ Market News

Clinical Trial Market Revenue to Cross $69.94 by 2027 Global Industry Size, Share, Trends, COVID-19 Analysis and Technology Advancements by Clinipace, Novo Nordisk, Pfizer, Sanofi, F. Hoffmann-La Roche Ltd, Alcami Corporation and Accell Clinical Research

author_avatar
NASDAQ Market News